Skip to main content
BioMedli
BioMedli
BiomarkersProtocolsBlogPricing
Log in
Biomarkers / Monocyte-to-HDL Ratio (MHR)
Core coverageDerived marker

Monocyte-to-HDL Ratio (MHR)

Monocyte-to-HDL Ratio (MHR) is a calculated lab index that combines same-date measurements to provide additional context alongside the source results.

BioMedli support

Extracted or calculated with provenance

On this page

OverviewClinical ImportanceResult InterpretationTesting GuideTechnical Details

What is Monocyte-to-HDL Ratio (MHR)?

The Monocyte-to-HDL Ratio (MHR) is a derived biomarker that reflects the balance between two key components of your cardiovascular and inflammatory systems: monocytes and High-Density Lipoprotein (HDL) cholesterol.

Understanding the players

Monocytes are a type of white blood cell that plays a critical role in the immune system. They are involved in the body's inflammatory response, helping to fight infections and clear cellular debris. However, elevated monocyte activity can also contribute to chronic inflammation, which is a known risk factor for various health conditions.

HDL cholesterol, often referred to as 'good' cholesterol, plays a crucial role in cardiovascular health. It helps transport excess cholesterol from the arteries back to the liver for removal, thereby preventing its buildup and reducing the risk of plaque formation. HDL also possesses anti-inflammatory and antioxidant properties.

The MHR calculation

By examining the ratio of monocytes to HDL, the MHR provides a consolidated view of inflammation and its potential impact on cardiovascular health. A higher ratio may indicate a pro-inflammatory state and a potential imbalance in cholesterol management, while a lower ratio generally suggests a more favorable inflammatory and cardiovascular profile.

Why is Monocyte-to-HDL Ratio (MHR) important?

The Monocyte-to-HDL Ratio (MHR) is clinically important as it offers a composite marker of inflammation and cardiovascular risk. It integrates the activity of monocytes, which can signal inflammation, with the cardioprotective function of HDL cholesterol. This combined metric can provide deeper insights than either component alone.

When levels drop too low

A low MHR generally suggests a more favorable state. It indicates either a lower number of circulating monocytes relative to HDL, or a higher HDL level relative to monocytes. This scenario is often associated with reduced systemic inflammation and a lower risk of cardiovascular events. It implies that the body's inflammatory response is well-regulated and that HDL is effectively performing its role in cholesterol transport and arterial health.

When levels climb too high

A high MHR can be a signal of increased systemic inflammation. This may occur if monocyte counts are elevated or if HDL cholesterol levels are low, or a combination of both. Elevated inflammation is a significant contributor to the development and progression of atherosclerosis (hardening of the arteries), increasing the risk of heart attack, stroke, and other cardiovascular diseases.

The long view on MHR

Consistently high MHR levels may be indicative of chronic inflammatory conditions that can silently damage blood vessels over time. This can impact long-term resilience and increase the likelihood of developing cardiovascular disease later in life. Conversely, maintaining a lower MHR can be a marker of sustained cardiovascular health and a robust defense against inflammatory processes.

What do my Monocyte-to-HDL Ratio (MHR) results mean?

Interpreting your Monocyte-to-HDL Ratio (MHR) involves understanding the interplay between monocytes and HDL cholesterol.

Low MHR levels

A low MHR is generally considered favorable. It suggests a state of lower systemic inflammation and robust cardiovascular protection. This can be due to a balanced inflammatory response, adequate HDL cholesterol levels, or both. Individuals with a low MHR may experience a reduced risk of cardiovascular events and inflammatory conditions.

Optimal MHR levels

Optimal MHR levels typically indicate a healthy balance between immune response and cardiovascular well-being. While specific numerical ranges can vary slightly depending on the laboratory and the individual's overall health profile, a consistently low ratio generally points towards a lower risk. This optimal state supports the body's ability to manage inflammation and maintain healthy arteries.

High MHR levels

A high MHR is often associated with increased systemic inflammation and a potentially elevated risk of cardiovascular disease. This can be driven by elevated monocyte counts, lower HDL cholesterol levels, or a combination. High MHR values may warrant further investigation into potential underlying inflammatory conditions or lifestyle factors contributing to cardiovascular risk.

Factors that influence MHR results

Several factors can influence MHR results. Acute infections or inflammatory conditions can temporarily elevate monocyte counts, thus increasing the ratio. Conversely, certain medications, lifestyle choices such as diet and exercise, and chronic diseases like diabetes or metabolic syndrome can impact both monocyte levels and HDL cholesterol. Pregnancy, due to its physiological changes, can also influence these markers. Therefore, MHR should always be interpreted within the context of an individual's complete health picture and in consultation with a healthcare professional.

Do I need a Monocyte-to-HDL Ratio (MHR) test?

Are you experiencing persistent fatigue, unexplained aches, or concerns about your heart health? Understanding your inflammatory status and cardiovascular markers might be key to unlocking your well-being.

The Monocyte-to-HDL Ratio (MHR) is a derived biomarker that offers a unique perspective on your body's inflammatory state and its potential impact on cardiovascular health. It provides a consolidated view by balancing immune cell activity with the protective role of HDL cholesterol.

Testing your MHR empowers you with actionable insights. It can help identify potential imbalances that may contribute to inflammation or cardiovascular risk, guiding you and your clinician to personalize lifestyle modifications and targeted health strategies for optimized resilience and long-term wellness.

Technical & PDF Reading Details

Measurement context

BioMedli calculates this only when all required source measurements are present on the same test date and their units can be normalized safely. Formula: absolute monocytes / HDL cholesterol.

How PDF reading works

Read directly when printed. Otherwise calculate from valid same-date source values and retain calculation provenance.

Calculation

absolute monocytes / HDL cholesterol

Required same-date inputs

  • Monocytes (Absolute)
  • HDL Cholesterol

Educational context only

BioMedli organizes laboratory information and trends. It does not diagnose disease, define a personal target, or replace a qualified healthcare professional.

Related biomarkers

High-sensitivity CRPFerritinCarbon Dioxide, TotalApolipoprotein BAtherogenic CoefficientAtherogenic Index of Plasma
Upload a report
Illustrated BioMedli health journey with lab reports, mountains, flowers, and people exploring health data

Private health intelligence

Make every lab report part of the story.

BioMedli turns scattered PDF lab reports into a private, searchable health timeline built for trends, protocols, and better questions at your next appointment.

Read yourselfExplore sample dashboard
BioMedli
BioMedli

A privacy-first lab report timeline for people who want to understand what changed, what matters, and what to retest next.

PDF parsingBiomarker trendsPrivate by default
BioMedli - Your longitudinal health intelligence layer | Product Hunt

Product

  • How It Works
  • Features
  • Biomarkers
  • Protocols
  • Pricing
  • Changelog

Learn

  • About
  • Upload Guide
  • Blog
  • Help Center
  • Safety
  • Contact

Legal

  • Privacy
  • Terms
  • Conditions
  • Cookie Policy
  • Refund Policy

© 2026 Terramedici LifeSciences LLP. All rights reserved.

BioMedli is an educational tool, not a diagnostic device, medical provider, or emergency service. Always consult with a qualified healthcare professional for clinical decisions.